Donna M Papsun

1.9k total citations
47 papers, 1.4k citations indexed

About

Donna M Papsun is a scholar working on Toxicology, Clinical Psychology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Donna M Papsun has authored 47 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Toxicology, 19 papers in Clinical Psychology and 16 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Donna M Papsun's work include Forensic Toxicology and Drug Analysis (39 papers), Psychedelics and Drug Studies (19 papers) and Opioid Use Disorder Treatment (16 papers). Donna M Papsun is often cited by papers focused on Forensic Toxicology and Drug Analysis (39 papers), Psychedelics and Drug Studies (19 papers) and Opioid Use Disorder Treatment (16 papers). Donna M Papsun collaborates with scholars based in United States, Belgium and Italy. Donna M Papsun's co-authors include Barry K. Logan, Alex J. Krotulski, Amanda L A Mohr, Sherri L. Kacinko, Melissa F. Fogarty, Melissa Friscia, Sara E. Walton, Marthe M. Vandeputte, Christophe P. Stove and Jeri D. Ropero‐Miller and has published in prestigious journals such as SHILAP Revista de lepidopterología, Analytical and Bioanalytical Chemistry and Journal of Organometallic Chemistry.

In The Last Decade

Donna M Papsun

45 papers receiving 1.3k citations

Peers

Donna M Papsun
Alex J. Krotulski United States
Amanda L A Mohr United States
Sherri L. Kacinko United States
George Behonick United States
Sarah Kerrigan United States
Alex J. Krotulski United States
Donna M Papsun
Citations per year, relative to Donna M Papsun Donna M Papsun (= 1×) peers Alex J. Krotulski

Countries citing papers authored by Donna M Papsun

Since Specialization
Citations

This map shows the geographic impact of Donna M Papsun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donna M Papsun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donna M Papsun more than expected).

Fields of papers citing papers by Donna M Papsun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donna M Papsun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donna M Papsun. The network helps show where Donna M Papsun may publish in the future.

Co-authorship network of co-authors of Donna M Papsun

This figure shows the co-authorship network connecting the top 25 collaborators of Donna M Papsun. A scholar is included among the top collaborators of Donna M Papsun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donna M Papsun. Donna M Papsun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Papsun, Donna M, et al.. (2025). Designer Fentanyl Precursors Leading the Way to New Fentanyl Analogs—The Case of ortho-Methylfentanyl. American Journal of Forensic Medicine & Pathology. 46(4). 365–367.
2.
Papsun, Donna M, et al.. (2025). New and Emerging “Nitazene” Analogues Appearing in Medicolegal Death Investigations. American Journal of Forensic Medicine & Pathology. 46(2). 180–182. 1 indexed citations
3.
Walton, Sara E., Bernadette V. Stang, Sherri L. Kacinko, et al.. (2025). Medetomidine quantitation and enantiomer differentiation in biological specimens collected after fatal and non-fatal opioid overdoses. Journal of Analytical Toxicology. 49(8). 551–558. 2 indexed citations
4.
Fogarty, Melissa F., Sara E. Walton, Grant C. Glatfelter, et al.. (2025). Toxicological evaluation, postmortem case descriptions, and pharmacological activity of N,N-dimethylpentylone and related analogs. Journal of Analytical Toxicology. 49(3). 143–151. 1 indexed citations
5.
Papsun, Donna M, et al.. (2024). Bromazolam in impaired driving investigations. Journal of Analytical Toxicology. 48(9). 653–658. 2 indexed citations
6.
Walton, Sara E., Eline Pottie, Donna M Papsun, et al.. (2024). In vitro structure–activity relationships and forensic case series of emerging 2-benzylbenzimidazole ‘nitazene’ opioids. Archives of Toxicology. 98(9). 2999–3018. 27 indexed citations
7.
Ellefsen, Kayla N., et al.. (2024). Seized drug reporting of NPS helps to guide regional toxicological practice: A 17 month review between 2022 and 2023. Journal of Forensic Sciences. 69(4). 1392–1399. 3 indexed citations
8.
Vandeputte, Marthe M., et al.. (2023). Detection, chemical analysis, and pharmacological characterization of dipyanone and other new synthetic opioids related to prescription drugs. Analytical and Bioanalytical Chemistry. 415(21). 5165–5180. 4 indexed citations
9.
Papsun, Donna M, et al.. (2023). Increasing prevalence of designer benzodiazepines in impaired driving: A 5-year analysis from 2017 to 2021. Journal of Analytical Toxicology. 47(8). 668–679. 11 indexed citations
10.
Vandeputte, Marthe M., Alex J. Krotulski, Donna Walther, et al.. (2022). Pharmacological evaluation and forensic case series of N-pyrrolidino etonitazene (etonitazepyne), a newly emerging 2-benzylbenzimidazole ‘nitazene’ synthetic opioid. Archives of Toxicology. 96(6). 1845–1863. 61 indexed citations
11.
Fogarty, Melissa F., Marthe M. Vandeputte, Alex J. Krotulski, et al.. (2022). Toxicological and pharmacological characterization of novel cinnamylpiperazine synthetic opioids in humans and in vitro including 2-methyl AP-237 and AP-238. Archives of Toxicology. 96(6). 1701–1710. 17 indexed citations
12.
Noble, Carolina, et al.. (2021). Detection of two potent synthetic opioids carfentanil and 3-methylfentanyl in forensic investigations during a four-year period 2017‒2020. SHILAP Revista de lepidopterología. 1. 100022–100022. 6 indexed citations
13.
Vandeputte, Marthe M., Alex J. Krotulski, Donna M Papsun, Barry K. Logan, & Christophe P. Stove. (2021). The Rise and Fall of Isotonitazene and Brorphine: Two Recent Stars in the Synthetic Opioid Firmament. Journal of Analytical Toxicology. 46(2). 115–121. 52 indexed citations
14.
Barenholtz, Elan, Alex J. Krotulski, Paul Morris, et al.. (2021). Online surveillance of novel psychoactive substances (NPS): Monitoring Reddit discussions as a predictor of increased NPS-related exposures. International Journal of Drug Policy. 98. 103393–103393. 30 indexed citations
16.
Kacinko, Sherri L. & Donna M Papsun. (2018). The Evolving Landscape of Designer Drugs. Methods in molecular biology. 1872. 129–135. 5 indexed citations
17.
Logan, Barry K., Amanda L A Mohr, Melissa Friscia, et al.. (2017). Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2013–2016: A Review. Journal of Analytical Toxicology. 41(7). 573–610. 126 indexed citations
18.
Papsun, Donna M, et al.. (2016). Analysis of MT-45, a Novel Synthetic Opioid, in Human Whole Blood by LC–MS-MS and Its Identification in a Drug-Related Death. Journal of Analytical Toxicology. 40(4). 313–317. 64 indexed citations
19.
Mohr, Amanda L A, et al.. (2016). Analysis of Novel Synthetic Opioids U-47700, U-50488 and Furanyl Fentanyl by LC–MS/MS in Postmortem Casework. Journal of Analytical Toxicology. 40(9). 709–717. 165 indexed citations
20.
Weisel, John W. & Donna M Papsun. (1987). Involvement of the cooh-terminal portion of the alpha-chain of fibrin in the branching of fibers to form a clot. Thrombosis Research. 47(2). 155–163. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026